An Evaluation of Blood Compatibility of Silver Nanoparticles

@article{Huang2016AnEO,
  title={An Evaluation of Blood Compatibility of Silver Nanoparticles},
  author={He Huang and Wenjia Lai and Menghua Cui and Ling Liang and Yuchen Lin and Qiaojun Fang and Ying Liu and Liming Xie},
  journal={Scientific Reports},
  year={2016},
  volume={6}
}
Silver nanoparticles (AgNPs) have tremendous potentials in medical devices due to their excellent antimicrobial properties. Blood compatibility should be investigated for AgNPs due to the potential blood contact. However, so far, most studies are not systematic and have not provided insights into the mechanisms for blood compatibility of AgNPs. In this study, we have investigated the blood biological effects, including hemolysis, lymphocyte proliferation, platelet aggregation, coagulation and… 
Effect of differently coated silver nanoparticles on hemostasis
TLDR
Evaluated silver nanoparticles effects on hemostasis in human blood demonstrate that a combination of different techniques should be used for reliable assessment of AgNPs hemostatic effects highlighting the need for a standardized approach in sampling and experimental protocols.
Surface Stabilization Affects Toxicity of Silver Nanoparticles in Human Peripheral Blood Mononuclear Cells
TLDR
This study provides systematic and comprehensive data showing how differently functionalized AgNPs may affect the human immune system and results are a valuable scientific contribution to safety assessment of nanosilver-based blood-contacting medical products.
Biogenic Synthesis of Antibacterial, Hemocompatible, and Antiplatelets Lysozyme Functionalized Silver Nanoparticles through the One-Step Process for Therapeutic Applications
TLDR
The results indicated that the antiplatelet potency and non-hemolytic nature with the antibacterial action of the lysozyme functionalized AgNPs have a good chance to be used to solve in-stent restenosis and thrombosis issues of the coronary stent and may also have a possibility to use in vaccination to resolve the blood clotting problem.
Assessment of Silver-Nanoparticles-Induced Erythrocyte Cytotoxicity through Ion Transport Studies.
TLDR
Findings indicate that HRBC K+ homeostasis is an early and sensitive biomarker for AgNPs toxicity and is a function of their surface functionalization.
Enhanced Hemocompatibility of Silver Nanoparticles Using the Photocatalytic Properties of Titanium Dioxide
Silver nanoparticles (AgNPs) are widely used because of their excellent antimicrobial properties. However, the poor hemocompatibility limits the application of AgNPs in blood contact materials.
Exploring the Heterogeneity of Nanoparticles in Their Interactions with Plasma Coagulation Factor XII.
TLDR
The interesting findings on the heterogeneity of NPs in their interactions with plasma FXII revealed the underlying mechanism for NP-triggered hematological responses, and suggested the crucial role of tuning NP parameters in their potential bioapplication, like nanodrug design.
Effect on Platelet Function of Metal-Based Nanoparticles Developed for Medical Applications
TLDR
This review focuses on the factors that can affect platelet activation and aggregation byMetal NPs and the nature of such interactions, providing a summary of the effect of various metal NPs on platelet function available in the literature.
EVALUATION OF NANOPARTICLES PYROGENICITY
TLDR
There will be need to develop alternative methods that may reliably detect endotoxin in nanoparticle samples when traditional methods cannot be used, and the appropriate method for detection of endotoxin is depending upon type of nanoformulations.
A review on nanostructured silver as a basic ingredient in medicine: physicochemical parameters and characterization
TLDR
The mechanism of action of AgNPs against various bacteria and viruses including the SARS-CoV-2 was analyzed in order to understand its effectiveness as an antimicrobial agent with therapeutic efficacy and low toxicity.
The in Vitro Effect of Polyvinylpyrrolidone and Citrate Coated Silver Nanoparticles on Erythrocytic Oxidative Damage and Eryptosis
TLDR
Both PVP- and CT- AgNPs causes hemolysis, and are taken up by erythrocytes, and these findings provide evidence for the potential pathophysiological effect of PVP -and CT-AgNPs on ERYthrocyte physiology.
...
...

References

SHOWING 1-10 OF 79 REFERENCES
Optimizing hemocompatibility of surfactant-coated silver nanoparticles in human erythrocytes.
TLDR
In the present study, human erythrocytes were used as an in vitro model to examine the size, dose, and coating surfactant-dependent cytotoxicity of silver nanoparticles and demonstrated that polyvinylpyrrolidone (PVP) was a more suitable surfactants than polyethylene glycol (PEG) for AgNPs capping.
Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles.
TLDR
Although significant size changes occurred to the silver particles due to interaction with media components, the higher level of in vitro hemolysis observed with nanoparticles compared with micron-sized particles may be related to their greater surface area, increased silver ion release, and direct interaction with RBCs.
Surface tunability of nanoparticles in modulating platelet functions.
Impact of Silver Nanoparticles on Haemolysis, Platelet Function and Coagulation
TLDR
It is demonstrated that Ag NPs induced haemolysis and increase platelet adhesion without having any impact on platelet aggregation, and they also had procoagulant potential.
Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism.
Method for analysis of nanoparticle hemolytic properties in vitro.
Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice, and other pathological conditions; therefore the hemolytic potential of all intravenously administered pharmaceuticals
...
...